(Q43210363)

English

Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure

scientific article published in January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 November 2017

Association of aldosterone concentration and mineralocorticoid receptor genotype with potassium response to spironolactone in patients with heart failure (English)

1 reference

Europe PubMed Central

16 November 2017

1 reference

based on heuristic

inferred from title

author name string

Larisa H Cavallari

1

1 reference

Europe PubMed Central

16 November 2017

Vicki L Groo

2

1 reference

Europe PubMed Central

16 November 2017

Marlos A G Viana

3

1 reference

Europe PubMed Central

16 November 2017

Yang Dai

4

1 reference

Europe PubMed Central

16 November 2017

Shitalben R Patel

5

1 reference

Europe PubMed Central

16 November 2017

Thomas D Stamos

6

1 reference

Europe PubMed Central

16 November 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

16 November 2017

Pharmacotherapy

1 reference

Europe PubMed Central

16 November 2017

30

1 reference

Europe PubMed Central

16 November 2017

1

1 reference

Europe PubMed Central

16 November 2017

1-9

1 reference

Europe PubMed Central

16 November 2017

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Clinical factors associated with hyperkalemia in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Incidence and predictors of hyperkalemia in patients with heart failure: an analysis of the CHARM Program

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Racial differences in potassium response to spironolactone in heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Racial differences in patients' potassium concentrations during spironolactone therapy for heart failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Functional polymorphisms in the mineralocorticoid receptor and amirolide-sensitive sodium channel genes in a patient with sporadic pseudohypoaldosteronism

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Aten

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Diurnal variation of aldosterone and plasma renin activity: timing relation to melatonin and cortisol and consistency after prolonged bed rest

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Effects of circadian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Point mutations close to the AUG initiator codon affect the efficiency of translation of rat preproinsulin in vivo

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.30.1.1

21 January 2018

Identifiers

10.1592/PHCO.30.1.1

1 reference

Europe PubMed Central

16 November 2017

1 reference

Europe PubMed Central

16 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43210363&oldid=1983881760"